Log In
Print
BCIQ
Print
Print this Print this
 

Oxytrol, oxybutynin (Oxytrol patch)

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionTransdermal tertiary amine anticholinergic agent
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat incontinence; Treat overactive bladder (OAB)
Regulatory Designation

Partner

Endo International plc; Merck & Co. Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today